Also, I want to emphasise that RAC is a one trick pony. Their new formula drug, RC220, has never been tested on humans. If the RAC human clinical trial fails, so will the RAC share price.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
34.0¢ |
Change
-0.025(6.85%) |
Mkt cap ! $75.80M | |||
| Open | High | Low | Value | Volume |
| 35.5¢ | 35.5¢ | 33.5¢ | $435.6K | 1.244M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 217639 | 34.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.5¢ | 4936 | 6 |
View Market Depth
| Last trade - 11.11am 22/07/2025 (20 minute delay) ? |
| IMU (ASX) Chart |